ROYALTY PHARMA PLC

Ticker: RPRX CUSIP: G7709Q104 Class: Common Stock

Vantage Consulting Group Inc's Holding History (CIK: 0001843547)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 57,500 Value ($000) $1,561 Avg Close $29.70 Range $25.92 - $31.55
Q2 2023
Shares 650,690 Value ($000) $20,002 Avg Close $33.87 Range $29.20 - $36.73
Q1 2023
Shares 1,022,194 Value ($000) $36,830 Avg Close $37.08 Range $32.68 - $39.92
Q4 2022
Shares 1,022,194 Value ($000) $35,462 Avg Close $41.74 Range $38.74 - $44.47
Q3 2022
Shares 1,022,194 Value ($000) $41,072 Avg Close $42.71 Range $39.60 - $44.66
Q2 2022
Shares 1,051,895 Value ($000) $44,222 Avg Close $40.99 Range $37.07 - $44.75
Q1 2022
Shares 2,727,854 Value ($000) $106,277 Avg Close $39.27 Range $36.15 - $42.62
Q4 2021
Shares 4,601,152 Value ($000) $183,355 Avg Close $38.85 Range $34.86 - $43.68
Q3 2021
Shares 7,862,542 Value ($000) $284,152 Avg Close $38.86 Range $35.55 - $42.89
Q2 2021
Shares 9,302,445 Value ($000) $381,307 Avg Close $42.54 Range $39.31 - $47.10
Q1 2021
Shares 8,705,551 Value ($000) $379,735 Avg Close $47.41 Range $39.63 - $53.23
Q4 2020
Shares 21,477,282 Value ($000) $1,074,938 Avg Close $42.43 Range $34.80 - $50.28